AlphaMadera's AlphaVal page computes EnerSys's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag ENS as undervalued, fairly valued, or overvalued.

What is EnerSys's fair value?

Fair value for ENS is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value ENS?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from ENS's most recent reported fundamentals.

ENS - EnerSys

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $265.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 35.5% above fair value

Current Price $227.95

Bear Case $147.15 35.4% downside ($147.15 - $227.95) / $227.95 = -35.4% $8.49 × 14x P/E

Fair Value $168.18 26.2% downside ($168.18 - $227.95) / $227.95 = -26.2% $8.49 × 16x P/E

Bull Case $189.19 17.0% downside ($189.19 - $227.95) / $227.95 = -17.0% $8.49 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

8.49$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 26.8x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $265.00 from 16 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $168.18 per share.

Warnings

ℹ Wall Street's average price target is $265.00 (from 16 analysts). Our estimate is 49% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples